INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2016

Oat β-glucan intake (2.5 to 3.5 g/day for 3 to 8 weeks) significantly lowered fasting plasma glucose and HbA1c in type 2 diabetes patients.

A meta-analysis of four randomized controlled trials evaluated the effects of oat β-glucan (OBG) in 350 patients with type 2 diabetes mellitus. Compared to controls, OBG intake of 2.5 to 3.5 g/day for 3 to 8 weeks significantly lowered fasting plasma glucose by -0.52 mmol/L (95% CI: -0.94, -0.10; p = 0.01) and HbA1c by -0.21% (95% CI: -0.40, -0.02; p = 0.03). However, OBG did not significantly alter fasting plasma insulin concentrations. The authors noted that data regarding the long-term effects of OBG intake on glycaemic control and insulin sensitivity were scarce.

Study type
Meta-analysis of randomized controlled trials
Who was studied
350 type 2 diabetes mellitus patients across four articles
What was measured
Fasting plasma glucose, HbA1c, and fasting plasma insulin

THE PAPER

Effect of Oat β-Glucan Intake on Glycaemic Control and Insulin Sensitivity of Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials.

Shen XL, Zhao T, Zhou Y, Shi X, Zou Y, Zhao G. Nutrients, 2016.

PubMed 26771637 ↗DOI 10.1111/j.1541-4337.2012.00189.x ↗

Diabetes & blood sugarNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.